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Immediate postoperative management and 
complications on the intensive care unit 
 
ABSTRACT 
The postoperative management of patients immediately after liver transplantation requires 
knowledge of this complex surgery and the physiology that accompanies liver failure. A 
multidisciplinary approach to the care of these patients is essential in order to reduce 
postoperative complications and preserve function in the transplanted organ. By their nature, 
patients undergoing liver transplantation have complicated medical problems before surgery 
which must be borne in mind when managing them after surgery. 
Haemorrhage, haemodynamic instability, acute renal failure, hepatic artery thrombosis and 
primary graft non-function are some of the complications that clinicians must be prepared for 
in the first days after transplantation. Pre-empting complications and acting rapidly to overt 
them is likely to have a considerable positive impact in these patients. 
 
 
INTRODUCTION 
Approximately 700 adult orthotopic liver transplants in the UK are performed each year 
across seven specialist centres (Martin et al, 2015). Patients with liver disease have 
multisystem effects of their illness, which affect the postoperative course. The complexity of 
the operation, the recipient’s physiology, the quality of the graft and the specific 
complications that can arise make care of the liver transplant patient uniquely challenging. 
This article discusses the outcome of liver transplantation and immediate postoperative 
management by organ system. The most common technical and non-technical complications 
are presented, including diagnosis and subsequent management of these complications. 
 
 
Clinical outcomes data 
National audit data for adult elective first orthotopic liver transplant in the UK across all 
centres show 90-day patient survival is 96%, and 92.4% of surviving patients had a functioning 
graft. Three-year patient survival decreases to 85.5%, and 5-year survival is 79.3%. For adult 
superurgent first liver transplant (in patients with fulminant hepatic failure), 90-day patient 
survival nationally is 91.5% with 90-day graft function of 88.7%. Three year patient survival is 
81.6% in this cohort, and 5-year survival is 81.2% (Martin et al, 2015). 
 
 
Immediate postoperative management 
Immediate postoperative management of the orthotopic liver transplant recipient requires 
close liaison with all the specialties involved in the transplantation process: surgeons, 
anaesthetists, hepatologists, radiologists, intensivists and specialist nurses. In general, the 
postoperative care is similar to that for major abdominal surgery, with additional focus on the 
management of the transplanted liver itself, on immunosuppression and on early detection 
of graft dysfunction or other complications. The usual model for postoperative management 
of the liver transplant recipient is to transfer the patient to an intensive care unit sedated, 
intubated and mechanically ventilated, although there is now a trend for early extubation in 
theatre or soon after arrival on the intensive care unit if appropriate (Biancofiore et al, 2001). 
From a cardiovascular perspective, maintenance of an adequate blood pressure is 
necessary to ensure optimal organ perfusion. Most patients have a high cardiac output with 
low systemic vascular resistance (particularly those with advanced cirrhosis), and require a 
vasopressor infusion (such as noradrenaline) to maintain a mean arterial pressure >65mmHg. 
Haemoglobin concentration is targeted at 80–100 g/litre and haematocrit at 0.26–0.32; it is 
important to avoid a high haematocrit to reduce the risk of thrombotic complications such as 
hepatic artery thrombosis (Buckels et al, 1989). Close monitoring of potassium and glucose 
levels is essential; patients often require supplementation of potassium in the first 36 hours 
after surgery. Analgesia is provided initially with a background opiate infusion, and as the 
majority of opioid metabolism is liver-dependent, these patients have reduced requirements 
compared to those undergoing major abdominal surgery (Aniskevich and Pai, 2015). Around 
a quarter of patients will have postoperative renal impairment, and renal replacement 
therapy will be required in those with a deteriorating renal function and low urine output 
despite adequate intravascular fluid resuscitation and renal perfusion. 
During this immediate postoperative phase, particular attention is paid to the function 
of the new liver and patency of its blood supply. Assessment of the latter by ultrasound 
Doppler of liver blood vessels is recommended for all patients in the first 24 hours. Liver 
function tests, lactate concentration and blood coagulation are monitored closely during this 
time (6-hourly to begin with) – many centres use dynamic clot function tests, such as 
thromboelastography, to assist with this assessment. Immunosuppression is often 
commenced intraoperatively with methylprednisolone given during the anhepatic phase, and 
then prescribed postoperatively by the hepatology team. The precise immunosuppression 
regimen will be determined according to individual patient characteristics. Bacterial infection 
is common post-orthotopic liver transplant, most often with Gram-negative bacteria, and 
adequate antimicrobial cover with vigilance for developing infection is essential. All patients 
should receive gastric ulcer prophylaxis, and enteral feeding is started if the patient remains 
sedated and unable to eat and drink, unless there are specific surgical contraindications. 
In these first postoperative days, therapies and monitoring (such as pulmonary artery 
catheter measurements and vasopressor support) are steadily de-escalated as dictated by the 
patient’s needs, with the aim of achieving ward level care within 24–48 hours if there are no 
immediate complications. 
 
 
Complications 
Postoperative complications are common post-orthotopic liver transplant, with over half of 
all patients developing at least one significant complication. Patients with complications have 
a longer length of stay in the intensive care unit and a longer hospital length of stay. This 
affects longer term outcome: graft failure and mortality at 90 days is higher in those who have 
had complications. High complication rates may be the result of increasing use of marginal 
quality organs, increasing number of donors after circulatory death, or the increasing burden 
of recipient comorbidities of patients on the liver transplant waiting list. 
 
 
 
Respiratory system 
Respiratory complications have been reported in up to 87% of patients post-orthotopic liver 
transplant (De Gasperi et al, 2014). These include infectious (early or late lower respiratory 
tract infections) and non-infectious (atelectasis, pleural effusion) complications. Chest 
physiotherapy, deep breathing exercises and early mobilization are all important after 
orthotopic liver transplant to prevent basal atelectasis and development of respiratory 
infections. 
More specific to this patient population is transfusion related lung injury in those who 
received blood or blood products during surgery. Other comorbidities include pulmonary 
hypertension (in approximately 8.5% of liver transplant patients), or hepatopulmonary 
syndrome (present in 10–30% of cirrhotic patients, where pulmonary vascular vasodilatation 
leads to pulmonary shunt), both of which can cause significant problems in orthotopic liver 
transplant. During reperfusion of the new liver, there is an acute rise in pulmonary artery 
pressure as a result of a rise in preload and cardiac output. In patients with pulmonary 
hypertension, the decrease in afterload is not appropriately balanced (Acosta et al, 2005), 
potentially leading to right ventricular dysfunction and a worse outcome. 
Complications can be caused by ineffective ventilation or oxygenation. Ineffective 
ventilation may be secondary to upper abdominal wall incisions, ascites, or paralysis of the 
right hemi-diaphragm as a result of damage to the phrenic nerve during surgery or following 
retraction. Ineffective oxygenation may result from atelectasis, prolonged intubation, pleural 
effusions, massive blood transfusion, acute respiratory distress syndrome, or a combination 
of these. 
There is a trend towards early extubation of these patients where possible 
(Biancofiore et al, 2001), which reduces length of time on a ventilator, reduces sedation and 
vasopressor use, and allows patients to start mobilizing earlier. Early extubation may not be 
achievable, however, and is less likely with increasing severity of liver disease, age, and 
complexity and duration of surgery. 
 
Cardiovascular system 
In end-stage liver disease, systemic and splanchnic arteriolar vasodilatation occurs as a 
response to progressive liver fibrosis and metabolic impairment, leading to a hyperdynamic, 
low resistance circulation (Møller and Bendtsen, 2015). Up to 50% of patients with cirrhosis 
will have features of cardiomyopathy associated with their cirrhosis and unrelated to alcohol 
consumption. This recently recognized clinical condition is often latent at rest, but evident at 
periods of stress. These patients display a blunted inotropic and chronotropic response to 
stress, such as during the reperfusion phase of orthotopic liver transplant (Rahman and 
Mallett, 2015). Owing to their altered circulation, patients may have high vasopressor 
requirements. During the perioperative phase of liver transplantation, care is taken to avoid 
pulmonary oedema, right heart overload and excess hepatic venous pressure. Hypotension 
can result from a systemic inflammatory response, hypovolaemia secondary to fluid shift or 
bleeding (as a result of coagulopathy, or bleeding from surgical sites).  
Of note, Marik et al (2005) showed that 92% of patients who had undergone recent 
orthotopic liver transplant with a steroid-sparing immunosuppressive regimen had adrenal 
insufficiency, which may present with hypotension, while the prevalence of subclinical 
adrenal insufficiency in patients with acute hepatic dysfunction is 62%. 
Hypertension can be a longer term complication following orthotopic liver transplant, 
present for a few days or weeks, or persisting for several months postoperatively. The exact 
cause is not clear – proposed aetiological factors include increased systemic vascular 
resistance resulting from catecholamine release during the stress response, manipulation of 
the right adrenal gland during surgery, hypothermia, hypervolaemia, renal insufficiency, and 
administration of calcineurin inhibitors. 
 
Neurological system 
Neurological complications after orthotopic liver transplant affect up to a third of patients 
(Campagna et al, 2010). Agitation is the most common complication post-orthotopic liver 
transplant, and complications may be a result of a combination of factors, such as a poorly 
functioning graft, immunosuppressant toxicity, metabolic and electrolyte abnormalities, 
infections, and hypertension or hypotension. These complications can be divided into 
metabolic-toxic complications (e.g. confusion, hallucinations, coma, pontine myelinolysis, 
posterior reversible encephalopathy syndrome) and non-metabolic complications (e.g. 
cerebral ischaemia, intracranial haemorrhage, subarachnoid bleeding, CNS infection). In a 
single centre prospective study (Bernhardt et al, 2015), patients in the metabolic-toxic group 
had a longer hospital length of stay and those in the non-metabolic group had an increased 
mortality rate compared to patients with no neurological complications. Diagnosis and 
treatment of neurological complications will differ depending on the cause, but a high index 
of suspicion is required given the prevalence of complications. As a late complication, many 
authors, including Bronster et al (2000), describe immunosuppressant toxicity, particularly 
calcineurin inhibitor toxicity, potentially causing microvascular injury and endothelial 
dysfunction, to be a diagnosis of exclusion. 
 
Gastrointestinal system 
Post-orthotopic liver transplant biliary complications occur in up to 5–25% of cases and have 
an associated increase in mortality. Biliary complications include anastomotic leaks, biliary 
strictures, non-anastomotic strictures and biliary obstruction. Anastomotic leaks result from 
breakdown of the surgical connection, insufficient bile duct arterialisation, or rarely from the 
resection surface of a split liver or living donor liver. Biliary strictures are most commonly 
caused by inadequate anastomoses, while non-anastomotic strictures are thought to be 
secondary to ischaemic events – hepatic artery thrombosis is a risk factor. Outflow 
obstruction can be caused by dysfunction of the sphincter of Oddi, as a result of inflammation 
or bile stones or casts. Cholangiography remains the gold standard investigation for biliary 
complications (Memeo et al, 2015).  
 
Renal function 
Acute kidney injury post-orthotopic liver transplant is common, with one large single centre 
study reporting an incidence of 52% at 72 hours post-orthotopic liver transplant (as defined 
by the Kidney Disease Improving Global Outcomes – KDIGO – criteria, namely a rise in serum 
creatinine level of >50% baseline preoperative value, or increase of 26.5 μmol/litre within 48 
hours from baseline, without urine output). Risk factors for acute kidney injury were 
identified as female sex, weight >100 kg, high Child–Pugh score, diabetes mellitus, and 
transfusion of blood or blood products. Patients who develop acute kidney injury have a 
reduced graft survival and increased mortality (Hilmi et al, 2015). About 10% of patients who 
develop acute kidney injury post-orthotopic liver transplant progress to end-stage renal 
failure (Razonable et al, 2011). The focus should be on prevention of acute kidney injury and 
early renal replacement therapy post-orthotopic liver transplant where required. 
Intraoperatively the risks can be reduced by avoiding hypotension and reducing requirements 
for blood products by inducing isovolaemic haemodilution. Surgical techniques that reduce 
manipulation of the inferior vena cava and optimize renal blood flow reduce postoperative 
acute kidney injury. Avoiding hyperglycaemia and nephrotoxic drugs (e.g. aminoglycosides), 
and delaying the introduction of calcineurin inhibitors until 72 hours post-orthotopic liver 
transplant have all been suggested to reduce the risk of developing acute kidney injury. 
The initiation of renal replacement therapy remains a clinical decision, with fluid 
overload and electrolyte derangement the most common factors prompting the 
commencement of renal replacement therapy. The majority of patients will regain long-term 
renal function following the immediate postoperative period. 
 
Coagulation 
In patients with end-stage liver disease, abnormal haematology results are common, e.g. 
thrombocytopaenia, coagulation factor deficiency, and fibrinolysis. Thrombocytopaenia is 
thought to result from a combination of bone marrow suppression, splenic sequestration and, 
where applicable, antiviral therapy. Coagulation factor deficiency results from the 
compromised capacity of the liver to synthesize proteins. Increased levels of tissue 
plasminogen activator in plasma and a decrease in the naturally-occurring inhibitors of 
plasmin result in hyperfibrinolysis in patients with end-stage liver disease. 
There is a newly emerging concept that blood coagulation in these patients is 
rebalanced as a result of a parallel reduction of procoagulant and anticoagulant factors. 
Patients with end-stage liver disease can have low levels of platelets but often have high levels 
of von Willebrand factor, such that platelet adhesion to the subendothelium in vascular injury 
is likely to be preserved (Tripodi and Mannucci, 2011). Prolongation of routine coagulation 
tests (prothrombin ratio, international normalized ratio and activated partial thromboplastin 
time) are all associated with liver disease, but are poorly predictive of bleeding in these 
patients. These assays are insensitive to the effect of natural anticoagulants, and measure 
time to the first clot, whereas newer tests such as thrombin generation assays give a clearer 
picture of overall coagulability (Habib et al, 2014). 
When assessing post-orthotopic liver transplant patients, consideration needs to be 
given to their bleeding and blood product use intraoperatively, and the trend of dynamic clot 
testing, e.g. thromboelastography. Post-orthotopic liver transplant, the risk of thrombosis 
(arterial, e.g. hepatic artery thrombosis, or venous, e.g. deep vein thrombosis) is high and 
could result in graft failure and need for urgent retransplantation. Therefore a moderate 
degree of bleeding is tolerated, where correction of prothrombin time and platelet count is 
avoided. Usual targets are to maintain haemoglobin at 8–10 g/dl and platelet count 
>20x109/litre. In addition, good postoperative care includes avoidance of hypothermia and 
targeted full anticoagulation in patients at high risk of hepatic artery thrombosis. Low or 
intermediate risk patients usually start a standard prophylactic anticoagulation protocol 
within 6 hours of orthotopic liver transplant provided there is no ongoing bleeding. High risk 
patients may be started on intravenous unfractionated heparin or regular treatment dose low 
molecular weight heparin. The rate of deep vein thrombosis and pulmonary embolism post-
orthotopic liver transplant is similar to that of other major surgeries (Emuakhagbon et al, 
2016). 
 
 
 
Infection 
Infectious complications are a leading cause of critical illness, morbidity and mortality after 
orthotopic liver transplant, with more than 50% of patients developing an infection during 
the first year after orthotopic liver transplant. Risk factors include prolonged surgery and 
hospitalization, gastrointestinal tract translocation, multiple catheter and drain insertions, 
and immunosuppression. This risk is reduced by standard perioperative antibacterial 
prophylaxis – third generation cephalosporins (e.g. cefotaxime) are preferred, although no 
single agent is widely recommended (Razonable et al, 2011). Early infections tend to be 
bacterial, although in this early period herpes simplex virus re-activation may lead to 
fulminant hepatic dysfunction and organ failure. Later opportunistic viral infections include 
cytomegalovirus, and fungal infections frequently involve Candida spp. in orthotopic liver 
transplant recipients (Razonable et al, 2011). 
 
 
Detection of graft failure 
Early graft failure is heralded by metabolic, cardiovascular and renal derangements. The 
reasons for failure of the graft include primary graft non-function, acute cellular rejection and 
ischaemia reperfusion injury. Primary graft nonfunction clinically presents as fulminant 
hepatic failure and coagulopathy, and may be evident before the patient has left the 
operating theatre or shortly after admission to intensive care. Primary graft non-function is 
uncommon (2–14% of orthotopic liver transplants) and requires urgent retransplantation. 
Risk factors include advanced age (of recipient and donor), prolonged graft ischaemia time, 
haemodynamic instability intraoperatively, and severe reperfusion damage. Different scoring 
systems for primary non-function exist in North America, Asia and Europe. For example, in 
the UK, the NHS Blood and Transplant Advisory Committee have set the criteria for early graft 
dysfunction (on days 0–7 after liver transplantation) with at least two of the following: 
aspartate transaminase >10 000 IU/litre, international normalized ratio >3.0, arterial lactate 
>3 mmol/litre, absence of bile production (Al-Freah et al, 2017). 
There is some evidence that ischaemic pre- and postconditioning of the graft during surgery 
improves graft histology, but improvements to clinical outcomes with these techniques have 
not been shown (Ricca et al, 2015). 
 
 
Complications of transplant 
Technical 
Hepatic artery thrombosis is a serious technical complication, occurring in 3% of orthotopic 
liver transplants, and is the most common technical complication to require 
retransplantation. Hepatic artery thrombosis acutely presents as fulminant hepatic ischaemic 
necrosis or can have a more insidious onset, usually within the first week following orthotopic 
liver transplant. Diagnosis is by a duplex ultrasound scan in the first instance, followed by 
triple-phase computed tomography or angiography. Urgent surgical exploration and 
assessment for re-anastomosis is the treatment of choice. Owing to the potentially 
devastating outcome from hepatic artery thrombosis, all patients have an ultrasound Doppler 
of liver vessels within 24 hours of orthotopic liver transplant. Risk factors for hepatic artery 
thrombosis include small vessels, ischaemic injury, multiple anastomoses or reconstruction, 
and a pro-thrombotic state. 
Portal venous thrombosis is much rarer (<1% of orthotopic liver transplants). This 
presents with symptoms including raised transaminase levels, ascites, gastrointestinal 
bleeding, intestinal congestion and bacterial translocation leading to systemic inflammatory 
response syndrome. Treatment options include thrombectomy, porto-systemic shunt 
insertion and retransplantation. Hepatic venous thrombosis is a very rare complication post-
orthotopic liver transplant. 
 
 
Non-technical 
Non-technical complications of transplantation include primary graft non-function (discussed 
previously), and immunological complications. Characteristics of the donor associated with 
liver graft failure have been incorporated into a donor risk index (Feng et al, 2006) aimed at 
reducing these complications. Early immunological complications include hyperacute 
rejection and acute cellular rejection. The former, hyperacute rejection, is an antibody-
mediated process caused by circulating antibodies formed at the time of transplantation. ABO 
incompatible grafts account for around 60% of cases. Management options such as antibody 
removal therapy (plasma exchange, B-cell depleting therapy), intravenous immunoglobulin 
administration, or surgery (splenectomy, retransplantation) can be considered. Acute cellular 
rejection occurs in 25–50% recipients within first 6 months post-orthotopic liver transplant, 
caused by sub-therapeutic immunosuppression. Management includes maintenance of 
optimum immunosuppression and steroids. Use of T-cell depletion therapies has been 
described. 
 
Conclusions 
The postoperative care of the liver transplant recipient requires an understanding of the 
operation and the potential impact of a patient’s comorbidities. Initial care should focus on a 
structured system-based approach with vigilance for postoperative complications, in 
particular respiratory and renal impairment, as these are the most likely to occur. Assessment 
and preservation of the blood supply to the new graft and the function of that graft is a 
priority in the first hours after transplant. Awareness of 
the technical and non-technical complications of liver transplant is important to ensure that 
when these occur, they are identified early on. As intraoperative point of care testing 
improves and becomes more widespread, and trends to early extubation and mobilization 
take hold, future orthotopic liver transplant recipients with fewer comorbidities and an 
uncomplicated operative course may be recovered in a postoperative critical care area rather 
than the intensive care unit.  
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KEY POINTS 
■Orthotopic liver transplantation is a complex procedure where close postoperative 
monitoring and management is essential to reduce complications and thereby improve 
outcomes. 
■Immediate postoperative management involves the principles of good general intensive 
care, including preparing for extubation, chest physiotherapy, maintenance of adequate 
perfusion pressure, monitoring and management of electrolytes and glycaemic control, fluid 
balance, stress ulcer prophylaxis and antimicrobial prophylaxis. 
■Optimal organ support can be achieved by taking a structured systems-based approach, 
where each aspect is optimized for perfusion and support of the new liver. 
■Specific attention is paid to limitation of postoperative complications which include hepatic 
or portal vein thrombosis, primary graft non-function and complications involving 
immunomodulation. 
■Early detection of graft failure is paramount to survival of patients. Identification involves 
monitoring of liver enzymes and liver function, in the form of measurement and detection of 
worsening coagulopathy and acidaemia, and clearance of lactate. 
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